femtocorp.com Open in urlscan Pro
185.60.170.168  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content
 * Home
 * Femtech
 * Products
 * Crm
 * Analytics
 * IR


 * Home
 * Femtech
 * Products
 * Crm
 * Analytics
 * IR

Contact us
 * Home
 * Femtech
 * Products
 * Crm
 * Analytics
 * IR


 * Home
 * Femtech
 * Products
 * Crm
 * Analytics
 * IR

Contact us

Femto is committed to developing and manufacturing top-tier, AI-enhanced women's
wellness devices and services, ensuring quality, effectiveness, and
affordability in everything we do




THE FUTURE OF FEMTECH

We aim to enhance women's lifestyles and wellness through cutting-edge
technology.

Our proprietary Slow-Release Tech is designed to embed oil and organic botanical
substances for multifaceted purposes. By harnessing the power of innovation, we
aim to transform daily living for women worldwide.


FEMTO CORE TECHNOLOGY

The Company's SRS (Smart Release System™) proprietary technology utilizes
advanced sensors to precisely detect, infuse, and personalize wellness
substances, aiming to regenerate women's physical and emotional balance




FEMTO PRODUCTS

Femto's product division focuses on three major anchors: Femto Intimacy,
harnessing the company's SRS (Smart Release System) proprietary technology to
develop and utilize advanced sensors that precisely detect, infuse, and
personalize wellness substances, aiming to support intimacy and well-being.
Femto Sports focuses on enhancing well-being experiences pre and post sports
activities. Femto Cosmetics concentrates on hair and facial aesthetics


SEXUAL WELLNESS DEVICE


YOUR GO-TO FOR MUSCLE RELIEF AND RELAXATION


NURTURING YOUR HAIR TO PERFECTION


REDEFINING SKINCARE WITH INTELLIGENCE


FEMTO ANALYTICS

Harnessing the power of big data and artificial intelligence to provide
unparalleled, data-driven insights regarding women's wellness. FEMTO owns and
markets a proprietary Customer Relationship Management (CRM) software product
known as 'Benefit CRM,' which enables small and medium-sized businesses to
optimize their day-to-day business activities.




FEMTO CRM





FEMTO TEAM


MOTI MARAM

President and Director


HAROLD WOLKIN

Director


YFTAH BEN YAACKOV

CEO and Director


DR. STEFÁNIA SZABÓ

Director


AVNER TAL

VP Sales & Marketing, CTO and Director


NIV SHIRAZI

Director


CARMEL ZIGDON

Director


GABI KABAZO

CFO and Director

we are here for you. anytime.

Contact us


INVESTORS RELATIONS

GWI predicts that the wellness economy will return to its robust growth,
projecting an average annual growth of 8.6%, with the wellness economy expected
to reach $8.5 trillion by 2027. The wellness economy represented 5.6% of global
economic output in 2022.*

 * Financial Filings
 * SEDAR
 * BYND Cannasoft December 2023 SEDAR
 * BYND Cannasoft MDA December 2023
 * Form of Proxy AGSM
 * Notice of Annual General and Special Meeting
 * VIG AGSM
 * Code of Conduct
 * Diversity Table




TINCIDUNT DIGNISSIM ANTE ARCU SAGITTIS

April 3, 2024


LAOREET MORBI AC VELIT UT.

April 3, 2024


LECTUS INTERDUM LIGULA ACCUMSAN

April 3, 2024


NULLA DICTUM MATTISSAD ASDSA

April 3, 2024


VELIT PHASELLUS. ULTRICES NISL LAOREET

April 3, 2024


TINCIDUNT DIGNISSIM ANTE ARCU SAGITTIS

April 2, 2024

All press releases


DISCLAIMER

This website contains forward-looking statements involving risks and
uncertainties that may cause actual results to differ materially from the
statements made. Such statements reflect our current views on future events and
are subject to such risks and uncertainties. Many factors may cause our actual
results to differ materially from those presented on the Site, including those
discussed in our filings with Canadian or U.S. securities regulatory
authorities. If one or more of these risks and uncertainties, such as currency
fluctuations and interest rates, increased competition, and general economic and
market factors, occur, or if the assumptions underlying the forward-looking
statements prove to be erroneous, Actual results may differ materially from
those described herein as intended, planned, predicted or expected. We do not
intend and assume no obligation to update these forward-looking statements,
except as required by law. The company intends to obtain approval for the EZ-G
patent within the usual timetables andto complete the development of the device
within the coming year. Additional regulatory standards may be required,
including FDA approval or any other approval for manufacturing, marketing and
selling the device or capsules under therapeutic indications. There is no
certainty that the foregoing approvals will be accepted and all information
hereunder is forward-looking. The model of the device appearingon the websiteis
not a working device and is a simulation as a concept model only and there is no
certainty that it will be compatible with the prototype of When the product is
manufactured in the future, there is also no certainty that the oils supplied
with the device will belong to Foria, and the matter is subject to the execution
of the agreements between the companies.Registration to the site is free of
charge and ordering the actual device will require monetary consideration as
presented by the company below. The Company reserves the right to terminate the
pre-registration process at any time and does not guarantee the timetables for
the supply of the products and/or that the product will eventually be supplied.


 * Home
 * Femtech
 * Products
 * Crm
 * Analytics
 * IR


 * Home
 * Femtech
 * Products
 * Crm
 * Analytics
 * IR


Contact us